A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
Infiltration (HVAC)
DOI:
10.1111/jcmm.15762
Publication Date:
2020-09-24T01:19:43Z
AUTHORS (6)
ABSTRACT
Current studies have shown that long non-coding RNAs (lncRNAs) may serve as prognostic biomarkers in multiple cancers. Therefore, we postulated expression patterns of lncRNAs combined into a single signature could improve clinicopathological risk stratification and prediction overall survival rate for breast cancer patients. Two algorithms, Least Absolute Shrinkage Selector Operation (LASSO) Support Vector Machine-Recursive Feature Elimination (SVM-RFE), were used to select candidate lncRNAs. Univariate multivariate Cox regression analyses employed construct seven-lncRNA cancer. Stratified analysis revealed the was significantly associated with factors. For clinical use, developed nomogram model predict odds death Single-sample gene set enrichment (ssGSEA), CIBERSORT algorithm ESTIMATE method assess relative immune cell infiltrations each sample. Differentially infiltration cells diverse tumour mutation burden (TMB) scores might give rise efficacy lncRNA predicting Correlation implied LINC01215 immune-related signalling pathways. A is reliable tool prognosis
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (92)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....